title: Acute dacryocystitis associated with epstein-barr virus infection.
abstract: Acute dacryocystitis is a rare complication of infectious mononucleosis with only three previous reports in the English literature. We present two further children with acute dacryocystitis and clinical and laboratory features of Epstein-Barr Virus related infectious mononucleosis. Both were treated with systemic antibiotics and one child additionally required surgical drainage of a lacrimal sac abscess. Both children made a complete recovery without any lacrimal symptoms. Acute dacryocystitis is uncommon in children without a history of congenital nasolacrimal duct obstruction, and an underlying systemic condition such as infectious mononucleosis should be suspected. In such patients, dacryocystitis can be expected to resolve without symptoms of nasolacrimal duct obstruction and dacryocystorhinostomy is seldom required.
authors.affiliation: Victoria Eye Unit, Hereford County Hospital, Hereford, United Kingdom.
authors.forename: Abdul-Jabbar
authors.initials: AJ
authors.lastname: Ghauri
authors.forename: Pearse A
authors.initials: PA
authors.lastname: Keane
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Scotcher
authors.forename: Jayne L
authors.initials: JL
authors.lastname: Clarke
authors.forename: Simon N
authors.initials: SN
authors.lastname: Madge
mesh_terms: D000208:Acute Disease; D002443:Ceftriaxone / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003607:Dacryocystitis / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D004322:Drainage / Q000379:methods; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007244:Infectious Mononucleosis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D007262:Infusions, Intravenous; D007767:Lacrimal Duct Obstruction / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D018570:Risk Assessment; D016896:Treatment Outcome
chemical_list: D008795:Metronidazole; D002443:Ceftriaxone